Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_assertion type Assertion NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_head.
- NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_assertion description "[A meta-analysis of 4,245 case and 5,982 control subjects indicated a null association of C282Y with diabetes risk, whereas carriers of H63D or the compound heterozygotes had marginally increased risk (odds ratio [OR] 1.11 [95% CI 1.00-1.25] and 1.60 [0.99-2.60], respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_provenance.
- NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_assertion evidence source_evidence_literature NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_provenance.
- NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_assertion SIO_000772 16306377 NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_provenance.
- NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_assertion wasDerivedFrom befree-20150227 NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_provenance.
- NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_assertion wasGeneratedBy ECO_0000203 NP991187.RAPWLZcazLjVcAwqK076Ydt7BEy5GEhHHjnWH7GUIcqiY130_provenance.